BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 17196290)

  • 1. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection.
    Donnelly RF; McCarron PA; Cassidy CM; Elborn JS; Tunney MM
    J Control Release; 2007 Feb; 117(2):217-26. PubMed ID: 17196290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of Methylene Blue and meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate from cross-linked poly(vinyl alcohol) hydrogels: a potential means of photodynamic therapy of infected wounds.
    Donnelly RF; Cassidy CM; Loughlin RG; Brown A; Tunney MM; Jenkins MG; McCarron PA
    J Photochem Photobiol B; 2009 Sep; 96(3):223-31. PubMed ID: 19651522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O.
    Donnelly RF; McCarron PA; Tunney MM; David Woolfson A
    J Photochem Photobiol B; 2007 Jan; 86(1):59-69. PubMed ID: 16963273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic Antimicrobial Chemotherapy (PACT) in combination with antibiotics for treatment of Burkholderia cepacia complex infection.
    Cassidy CM; Donnelly RF; Elborn JS; Magee ND; Tunney MM
    J Photochem Photobiol B; 2012 Jan; 106():95-100. PubMed ID: 22079165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sub-lethal challenge with Photodynamic Antimicrobial Chemotherapy (PACT) on the antibiotic susceptibility of clinical bacterial isolates.
    Cassidy CM; Donnelly RF; Tunney MM
    J Photochem Photobiol B; 2010 Apr; 99(1):62-6. PubMed ID: 20207552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug and light delivery strategies for photodynamic antimicrobial chemotherapy (PACT) of pulmonary pathogens: a pilot study.
    Cassidy CM; Tunney MM; Magee ND; Elborn JS; Bell S; Singh TR; Donnelly RF
    Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):1-6. PubMed ID: 21333929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toluidine blue O photodynamic inactivation on multidrug-resistant Pseudomonas aeruginosa.
    Tseng SP; Teng LJ; Chen CT; Lo TH; Hung WC; Chen HJ; Hsueh PR; Tsai JC
    Lasers Surg Med; 2009 Jul; 41(5):391-7. PubMed ID: 19533759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung.
    Musk DJ; Hergenrother PJ
    J Appl Microbiol; 2008 Aug; 105(2):380-8. PubMed ID: 18284482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation.
    Wu H; Lee B; Yang L; Wang H; Givskov M; Molin S; Høiby N; Song Z
    FEMS Immunol Med Microbiol; 2011 Jun; 62(1):49-56. PubMed ID: 21303421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How much do Pseudomonas biofilms contribute to symptoms of pulmonary exacerbation in cystic fibrosis?
    VanDevanter DR; Van Dalfsen JM
    Pediatr Pulmonol; 2005 Jun; 39(6):504-6. PubMed ID: 15830388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
    Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
    J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.